Novartis reported Q2 core earnings of $2.41 per share, surpassing analyst expectations of $2.17.
Novartis (NVS) stock climbed after the company posted second-quarter core earnings of $2.41 per share on $14.41 billion in sales. The results exceeded analysts’ forecasts, which had anticipated $2.17 per share and $14.07 billion in revenue.
In the same period last year, Novartis earned $2.42 per share on $14.05 billion in sales. The company’s performance was driven by strong demand for its key products, contributing to the earnings beat.
Shares of Novartis showed upward momentum following the release, reflecting investor confidence in the quarterly results.